Spots Global Cancer Trial Database for previously treated childhood rhabdomyosarcoma
Every month we try and update this database with for previously treated childhood rhabdomyosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features | NCT01048892 | Adrenocortical ... Gastrointestina... Kidney Cancer Neuroblastoma Retinoblastoma Sarcoma | Seneca Valley v... cyclophosphamid... laboratory biom... pharmacological... | 3 Years - 21 Years | Children's Oncology Group | |
| Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma | NCT01222715 | Adult Rhabdomyo... Childhood Alveo... Childhood Pleom... Childhood Rhabd... Previously Trea... Recurrent Adult... Recurrent Child... | Bevacizumab Cyclophosphamid... Laboratory Biom... Temsirolimus Vinorelbine Tar... | - 29 Years | National Cancer Institute (NCI) | |
| Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma | NCT00006102 | Brain and Centr... Lymphoma Neuroblastoma Retinoblastoma Sarcoma Unspecified Chi... | becatecarin | - 21 Years | National Cancer Institute (NCI) | |
| Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma | NCT01626170 | Alveolar Childh... Embryonal Child... Previously Trea... Previously Untr... Recurrent Child... | laboratory biom... | - | Children's Oncology Group | |
| Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma | NCT01626170 | Alveolar Childh... Embryonal Child... Previously Trea... Previously Untr... Recurrent Child... | laboratory biom... | - | Children's Oncology Group | |
| Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma | NCT01365962 | Sarcoma | gene expression... immunohistochem... laboratory biom... mass spectromet... | - | Children's Oncology Group | |
| Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma | NCT00055939 | Sarcoma | exatecan mesyla... | - | Daiichi Sankyo | |
| Biomarkers in Samples From Young Patients With Soft Tissue Sarcoma | NCT01342783 | Sarcoma | DNA analysis RNA analysis mutation analys... nucleic acid se... laboratory biom... | - 18 Years | Children's Oncology Group | |
| Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma | NCT00003801 | Long-term Effec... Sarcoma | management of t... quality-of-life... | 5 Years - | National Cancer Institute (NCI) | |
| Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma | NCT00919269 | Adult Rhabdomyo... Childhood Desmo... Chordoma Desmoid-Type Fi... Metastatic Chil... Non-Metastatic ... Previously Trea... Recurrent Adult... Recurrent Child... Recurrent Child... Rhabdomyosarcom... Stage I Adult S... Stage II Adult ... Stage III Adult... Stage IV Adult ... Untreated Child... | Cytology Specim... Laboratory Biom... | - 50 Years | Children's Oncology Group | |
| Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma | NCT01609803 | Alveolar Childh... Embryonal Child... Previously Trea... Previously Untr... Recurrent Child... | laboratory biom... | - 21 Years | Children's Oncology Group | |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer | NCT01132547 | Cancer | cyproheptadine ... placebo | 2 Years - 21 Years | University of South Florida | |
| Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma | NCT00025363 | Alveolar Childh... Embryonal Child... Embryonal-botry... Previously Trea... Recurrent Child... | vincristine sul... irinotecan hydr... cyclophosphamid... doxorubicin hyd... ifosfamide etoposide tirapazamine filgrastim sargramostim pharmacological... pharmacogenomic... laboratory biom... | - 20 Years | National Cancer Institute (NCI) | |
| Protein Expression in Samples From Young Patients With Rhabdomyosarcoma | NCT01426945 | Sarcoma | protein express... immunohistochem... laboratory biom... | - | Children's Oncology Group | |
| Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma | NCT01609803 | Alveolar Childh... Embryonal Child... Previously Trea... Previously Untr... Recurrent Child... | laboratory biom... | - 21 Years | Children's Oncology Group | |
| Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma | NCT00003801 | Long-term Effec... Sarcoma | management of t... quality-of-life... | 5 Years - | National Cancer Institute (NCI) | |
| Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features | NCT01048892 | Adrenocortical ... Gastrointestina... Kidney Cancer Neuroblastoma Retinoblastoma Sarcoma | Seneca Valley v... cyclophosphamid... laboratory biom... pharmacological... | 3 Years - 21 Years | Children's Oncology Group | |
| Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma | NCT00003801 | Long-term Effec... Sarcoma | management of t... quality-of-life... | 5 Years - | National Cancer Institute (NCI) | |
| Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors | NCT00070109 | Previously Trea... Recurrent Child... Recurrent Child... Recurrent Ewing... Peripheral Prim... | trabectedin pharmacological... | 12 Months - 50 Years | Children's Oncology Group | |
| Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma | NCT00025363 | Alveolar Childh... Embryonal Child... Embryonal-botry... Previously Trea... Recurrent Child... | vincristine sul... irinotecan hydr... cyclophosphamid... doxorubicin hyd... ifosfamide etoposide tirapazamine filgrastim sargramostim pharmacological... pharmacogenomic... laboratory biom... | - 20 Years | National Cancer Institute (NCI) | |
| Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma | NCT01365962 | Sarcoma | gene expression... immunohistochem... laboratory biom... mass spectromet... | - | Children's Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
